Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Ted Shaub

Interventional Cardiology Akron, OH Medical Doctor

NPI 1275538720 CMS profile 238851

75 Arch St Ste 206, Akron, OH 44304

Open in the dashboard

General payments

$301

6 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Through program year 2021, Ted Shaub of Akron, OH is reported in the CMS Open Payments database as having received $301 across 6 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 6th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $27 1
2020 General $12 1
2019 General $262 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ted Shaub
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Ted Shaub were reported at $0. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Ted Shaub Interventional Cardiology median Middle half National median
2019 $262 $1,097 $329–$3,048 $163
2020 $12 $473 $161–$1,480 $114
2021 $27 $677 $233–$1,827 $132
2022 $0 $978 $333–$2,724 $149
2023 $0 $1,136 $382–$2,986 $160
2024 $0 $1,181 $395–$3,326 $164
2025 $0 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Actelion Pharmaceuticals US, Inc. $107 2 payments
  2. Lundbeck LLC $84 1 payment
  3. Medtronic Vascular, Inc. $72 1 payment
  4. UCB, Inc. $27 1 payment
  5. Mayne Pharma Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $301 6 payments
Products named General payments · program years 2019–2021
  1. NORTHERA $84 1 payment
  2. Avalus $72 1 payment
  3. Briviact $27 1 payment
  4. OPSUMIT $12 1 payment
  5. UPTRAVI $12 1 payment
  6. DORYX $11 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 69 drugs

Part D claims

6,298

Median for Cardiology: 2,533

Drug cost

$3,768,307

Median for Cardiology: $485,213

Branded share of claims

33.1%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Vyndamax Tafamidis Brand 38 $1,261,236
Eliquis Apixaban Brand 675 $1,060,993
Xarelto Rivaroxaban Brand 402 $600,132
Entresto Sacubitril/Valsartan Brand 331 $534,396
Jardiance Empagliflozin Brand 42 $71,262
Repatha Sureclick Evolocumab Brand 36 $44,214
Farxiga Dapagliflozin Propanediol Brand 26 $43,191
Trulicity Dulaglutide Brand 22 $21,195
Corlanor Ivabradine Hcl Brand 14 $17,812
Breo Ellipta Fluticasone/Vilanterol Brand 33 $15,153

The 10 drugs with the highest cost, of 69 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 14 billing codes

Paid by Medicare

$34,559

Medicare's payments for the services billed

Medicare patients

279

Average age 77

Services billed

512

112 women, 167 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Atrial fibrillation 49%
Arthritis 48%
Diabetes 36%
Chronic kidney disease 34%
Heart failure 29%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

6 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record